Shares of drug maker Dr. Reddy's Laboratories plunged over 5 per cent, hitting the 52-week low, on the Bombay Stock Exchange amid a spurt in volume trade after that US FDA found repeat observations from 2015 warning letter. According to ET Now, the company has failed to maintain complete data to ensure compliance.
Best services products with best technical support which will make your Financial Trading easy let us know you more click here for the next level >> http://www.ripplesadvisory.com/free-trial.php Or in ONE MISSED CALL ON @9644405056
Shares of drug maker Dr. Reddy's Laboratories plunged over 5 per cent, hitting the 52-week low, on the Bombay Stock Exchange amid a spurt in volume trade after that US FDA found repeat observations from 2015 warning letter. According to ET Now, the company has failed to maintain complete data to ensure compliance.
No comments:
Post a Comment